Xenoport

Provider of biopharmaceutical products for neurological disorders and pain management

placeSanta Clara, California, United States calendar_todayFounded 1999 groups156 employees language xenoport.com

Innovation

136 patent families (84 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 24,477 times.

YearFilings
201232
201325
201422
201522
201624
201711
20186
20195
20202
20212

Investor mix

19 investors on record; lead investors include HBM Healthcare Investments; 1 has since exited.

Investor typeCountShare
Venture capital1368%
Private equity211%
Angel & family office15%
Other / undisclosed316%
Coming soon